Cargando…
Mortality after drug-eluting stents vs. coronary artery bypass grafting for left main coronary artery disease: a meta-analysis of randomized controlled trials
AIMS : The optimal method of revascularization for patients with left main coronary artery disease (LMCAD) is controversial. Coronary artery bypass graft surgery (CABG) has traditionally been considered the gold standard therapy, and recent randomized trials comparing CABG with percutaneous coronary...
Autores principales: | Ahmad, Yousif, Howard, James P, Arnold, Ahran D, Cook, Christopher M, Prasad, Megha, Ali, Ziad A, Parikh, Manish A, Kosmidou, Ioanna, Francis, Darrel P, Moses, Jeffrey W, Leon, Martin B, Kirtane, Ajay J, Stone, Gregg W, Karmpaliotis, Dimitri |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7557472/ https://www.ncbi.nlm.nih.gov/pubmed/32118272 http://dx.doi.org/10.1093/eurheartj/ehaa135 |
Ejemplares similares
-
Amphilimus- vs. zotarolimus-eluting stents in patients with diabetes mellitus and coronary artery disease: the SUGAR trial
por: Romaguera, Rafael, et al.
Publicado: (2021) -
Complete Revascularization by Percutaneous Coronary Intervention for Patients With ST‐Segment–Elevation Myocardial Infarction and Multivessel Coronary Artery Disease: An Updated Meta‐Analysis of Randomized Trials
por: Ahmad, Yousif, et al.
Publicado: (2020) -
Pharmacogenetics-guided dalcetrapib therapy after an acute coronary syndrome:
the dal-GenE trial( )
por: Tardif, Jean Claude, et al.
Publicado: (2022) -
Coronary computed tomography angiography for heart team decision-making in multivessel coronary artery disease
por: Collet, Carlos, et al.
Publicado: (2018) -
β-blockers, calcium antagonists, and mortality in stable coronary artery disease: an international cohort study
por: Sorbets, Emmanuel, et al.
Publicado: (2019)